Janus Kinase 3, antagonists & inhibitors
- Name
- Janus Kinase 3, antagonists & inhibitors
- Accession Number
- DBCAT001910
- Description
Not Available
- Drugs
Drug Drug Description Tofacitinib A Janus kinase (JAK) inhibitor used to treat rheumatic conditions, such as rheumatoid arthritis and ankylosing spondylitis, and ulcerative colitis. Ritlecitinib A kinase inhibitor used to treat severe alopecia areata in adults and adolescents 12 years and older. - Drugs & Drug Targets